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Have you treated?
1. 22 yo female G4P1021 at ROB visit with HgB 8.1 not taking her iron
pills because “they make her stomach” hurt?
2. 41 yo female with dizziness and AUB-L in ED with HgB 5.3?
3. 53 yo female with PMB and diagnosis of carcinosarcoma with HgB
6.1 ?

Research project
1. Identify women who will benefit from IV iron

2. Collaborate with hematology to facilitate scheduling and
administering IV iron
3. Assess improvement of quality of life with help of questionnaires and
lab work

Target population
1. Females with IDA secondary to heavy menstruation
2. OB population (antepartum + postpartum)

3. Chronic blood loss secondary to GYN/GYN ONC etiology

Inclusion Criteria
• > 18 yo
• IV treatment indicated
• Low HgB <14
• Ferritin <100
• Documented unsatisfactory
oral iron therapy or iron
cannot be tolerated

• Agree to sign consent for
survey pre-treatment and
post-treatment 30 and 60
days

Exclusion criteria
• Severe hepatic impairment
• Known allergy to parenteral iron
• Anemia not associated with IDA
• Pre-existing cardiovascular
diseased
• Dialysis dependent CKD

Study endpoints
• Primary:
• Assessment of patient’s symptoms using questionnaires
• Quality of life score on all patients
• Mean change in hemoglobin from baseline to week 4 and week 8

• Secondary:
• Safety events – hypersensitivity reactions  flushing, wheezing, anaphylaxis
• Cost of treatment of IV iron outpatient

DOSING
• Non pregnant: Calculate iron replacement with formula
• Iron deficit (mg) = (Desired HgB – observed HgB) x actual wt in lbs + 600

• Pregnant: Fixed dose of 1000 mg of IV iron dextran

Questionnaires
• PROMIS 1.0 questionnaire
• Healthy Days Core Module (CDC HRQOL- 4)
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Contact persons
• Laura Gusba, CNP - lgusba1@hfhs.org
• Dr. Marian Girgis, MD (Hem-onc fellow) – mgirgis2@hfhs.org

• Dr. Aparna Bas, MD (Hem-onc fellow) - abasu1@hfhs.org
• Inpatient HEM-ONC consult pager - 0722
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